Ozempic and Cancer Prevention: Why Observational Studies Don't Prove Risk Reduction

Doctors caution that while GLP-1 drugs like Ozempic show lower cancer rates in observational data, healthy-user bias and short follow-up periods mean prevention remains unproven.

25 Aug, 13:17 — 25 Aug, 13:17

Post Share

Sources

Showing 1 of 1 sources

Daily MaverickMostly Factual7h ago

THE CONVERSATION: Can Ozempic prevent cancer? A doctor explains why the headlines are easy to misread

GLP-1 drugs like Ozempic appear linked to lower rates of some cancers in observational studies, yet healthy-user bias and short follow-up mean prevention remains unproven.

By Ziyad Al-Aly

Read full article →

PERSPECTA

PERSPECTA

Ozempic and Cancer Prevention: Why Observational Studies Don't Prove Risk Reduction

Sources

THE CONVERSATION: Can Ozempic prevent cancer? A doctor explains why the headlines are easy to misread

Related Stories

New Study Reveals High CTE Prevalence in Former NFL Players

Sandra Bullock Discusses Children's Reaction to Partner's ALS Battle

West Nile Virus Cases Rise in Balkan Region

Extreme Heat Causes 35,000 Excess Deaths in Europe

PERSPECTA